文献库 文献相关信息

题目:
Surface antigens of immunoprotective leukaemia x fibroblast hybrid cells which have lost malignant properties in histocompatible mice differ from the malignant parental cells.
作者:
Slomski(R),Wang(D R),Cohen(E P)
状态:
发布时间1984-07-27 , 更新时间 2016-10-19
期刊:
Immunology
摘要:
Somatic hybrids of ASL-1 leukaemia cells and LM(TK-) fibroblast cells, established mouse cell lines, are rejected by immunocompetent histocompatible mice; however, they grow progressively in nude mice and proliferate indefinitely in vitro. Mice rejecting such hybrid cells exhibit immunity toward ASL-1 leukaemia cells, used as one of the parents in forming the hybrid. In histocompatible recipients, ASL-1 cells are highly malignant, but LM(TK-) cells are rejected. Several distinguishing characteristics in the properties of the surface antigens of the three cell types are described. ASL-1 cells and hybrid cells but not LM(TK-) cells form an antigenically cross-reactive leukaemia-associated antigen; however, it is not detected on the surface membranes of ASL-1 cells taken directly from leukaemic mice. The antigen becomes apparent after short-term culture of the cells. Serum from leukaemic animals, unlike specific antibodies, has no effect upon the expression of the leukaemia-associated antigen of either hybrid or ASL-1 cells. Hybrid cells form a 'second' antigen, foreign to F1 mice, which can be distinguished from the leukaemia-associated antigen of ASL-1 cells. It is not detected on either parental cell. The leukaemia-associated antigen of ASL-1 cells is more readily digested by each of three proteases used than the analogous antigen of hybrid cells. The heightened immunogenic properties of hybrid cells is reflected by the observation that spleen cells from mice injected with hybrid cells undergo extensive proliferation in short-term in vitro culture, with or without an added specific stimulus.
语言:
eng
DOI:

联系方式

山东省济南市章丘区文博路2号 齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号大学科技园北区F座4单元2楼

电话: 0531-88819269

E-mail: product@genelibs.com

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。